Innobic sells entire AMOLH stakeBuranin Rattanasombat, chairman of Innobic (Asia)Innobic (Asia) Co, the life sciences arm of national oil and gas conglomerate PTT Plc, has sold its entire stake in its pharmaceutical firm to restructure, aiming to refocus in the segment. Innobic holds shares in AMOLH through its subsidiary Alvogen Emerging Markets Holdings. It holds a 37% share in Lotus Pharmaceutical. Up to 85% of the earnings came from Lotus Pharmaceutical. Innobic is preparing to build a 1.3-billion-baht production facility of active pharmaceutical ingredients, which contain active ingredients able to relieve illnesses.
